
MDS Papers
Groups at MDS publish and release a variety of papers to advance the field of Movement Disorders.
Featured
Evidence-Based Medicine Reviews:
White paper: Research Priorities for Gait and Balance Disturbances in Parkinson’s Disease (2022)
All MDS Papers
These papers represent the work of various MDS Task Forces, Committees, and Study Groups to address areas in the field of Movement Disorders. Their results and efforts further the clinical and scientific mission of the Society. They include position papers, critiques, and recommendations on rating scales, guidelines, and reports.
![]()
International Parkinson and Movement Disorder Society Clinical Outcome Assessments are Available in REDCap
March 2026- Rating Scales
- Published paper
![]()
MDSGene Systematic Review of Common Forms of Dominant Hereditary Spastic Paraplegia: Novel Insights
February 2026- Genetic & Hereditary Disorders
- Published paper
![]()
International Registry of NKX2-1-Related Disorders: Clinical, Genetic, and Imaging Perspectives
January 2026- Genetic & Hereditary Disorders
- Neuropsychiatric symptoms
- Published paper
![]()
MDS PD e-Diary: A New Patient-Centered Digital Tool in Development for People with Parkinson's Disease
December 2025- Published paper
![]()
Complementary and Integrative Medicine for the Treatment of Tourette's Syndrome
December 2025- Complementary and Alternative Medicine
- Tics/Tourettes syndrome (TS)
- Published paper
![]()
‘What's in a Name?’ Naming Genetically Determined Movement Disorders: Gap and Controversy
November 2025- Published paper
![]()
Clinical and Radiological Evolution of Idiopathic Normal Pressure Hydrocephalus: A Critical Review
November 2025- Gait & Balance Disorders
- Published paper
![]()
Assessing Digital Health Technologies for Outcome Measurement in Parkinson's Disease Drug Trials: A Systematic Review
November 2025- Clinical Trials
- Published paper
![]()
Clinical Outcome Assessments in Parkinson's Disease: A Scoping Review of Current Rating Scales and Future Needs
October 2025- Rating Scales
- Published paper
![]()
Longitudinal Evaluation of an Abbreviated Patient-Reported Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) for Predicting Dopaminergic Therapy Initiation in Early Parkinson's Disease
October 2025- Dopaminergic medications
- Rating Scales
- Published paper
![]()
RAB32-Linked Parkinson's Disease: Deep Phenotyping, MDSGene Literature Review, and Application of SynNeurGe Criteria
October 2025- Genetics
- Published paper
![]()
A Holistic Wellness Prescription for Parkinson's Disease: Evidence-Based Perspectives and Unmet Needs
October 2025- Published paper
Perspective: Behind the science
Scaling clinical guidelines for a global audience
“... A guideline, to me, is dangerous because it doesn't put you in the context of the very patient you're dealing with. So we took a different strategy.”
Christopher Goetz, MD, shares why MDS moved away from traditional medical guidelines, and how the Society instead evaluates treatments with an adaptable methodology that can account for geographical and cultural differences across global contexts.




